Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon R Lewin

Showing results (51-60 of 378) with videos related to

Pageof 38
Sort By:
Ebiomedicine|February 5, 2022
Immune checkpoint blockade in HIVCeline Gubser, Chris Chiu, Sharon R Lewin, et al.
Plos Pathogens|October 27, 2015
Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected CellsRuian Ke, Sharon R Lewin, Julian H Elliott, et al.
EJNMMI Reports|June 6, 2024
Response to COVID-19 vaccination imaged by PD-L1 PET scanningMichael P MacManus, Tim Akhurst, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV controlMichael A Moso, Michael Roche, Paula M Cevaal, et al.
Frontiers in Immunology|April 28, 2025
HIV Tat as a latency reversing agent: turning the tables on viral persistenceBridget M Fisher, Paula M Cevaal, Michael Roche, et al.
Journal of the International AIDS Society|December 20, 2019
Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latencyYoury Kim, Paul U Cameron, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|September 9, 2016
Cancer therapies in HIV cure researchThomas A Rasmussen, Jenny L Anderson, Fiona Wightman, et al.
Journal of Leukocyte Biology|October 26, 2013
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesPaul R Gorry, Nicholas Francella, Sharon R Lewin, et al.
The Lancet. HIV|January 15, 2016
Ethics of ART interruption after stem-cell transplantationJeremy Sugarman, Sharon R Lewin, Timothy J Henrich, et al.
Clinical & Experimental Ophthalmology|March 17, 2007
Immune recovery uveitis in an HIV-negative individualMichelle L Baker, Penelope Allen, Jake Shortt, et al.
Pageof 38

Showing results (51-60 of 378) with videos related to

Sort By:
Pageof 38
Ebiomedicine|February 5, 2022
Immune checkpoint blockade in HIVCeline Gubser, Chris Chiu, Sharon R Lewin, et al.
Plos Pathogens|October 27, 2015
Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected CellsRuian Ke, Sharon R Lewin, Julian H Elliott, et al.
EJNMMI Reports|June 6, 2024
Response to COVID-19 vaccination imaged by PD-L1 PET scanningMichael P MacManus, Tim Akhurst, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV controlMichael A Moso, Michael Roche, Paula M Cevaal, et al.
Frontiers in Immunology|April 28, 2025
HIV Tat as a latency reversing agent: turning the tables on viral persistenceBridget M Fisher, Paula M Cevaal, Michael Roche, et al.
Journal of the International AIDS Society|December 20, 2019
Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latencyYoury Kim, Paul U Cameron, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|September 9, 2016
Cancer therapies in HIV cure researchThomas A Rasmussen, Jenny L Anderson, Fiona Wightman, et al.
Journal of Leukocyte Biology|October 26, 2013
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesPaul R Gorry, Nicholas Francella, Sharon R Lewin, et al.
The Lancet. HIV|January 15, 2016
Ethics of ART interruption after stem-cell transplantationJeremy Sugarman, Sharon R Lewin, Timothy J Henrich, et al.
Clinical & Experimental Ophthalmology|March 17, 2007
Immune recovery uveitis in an HIV-negative individualMichelle L Baker, Penelope Allen, Jake Shortt, et al.
Pageof 38